Skip to main content
SpringerLink
Log in

Indications for Implantable Cardioverter-Defibrillators

  • Chapter
  • First Online:
Management of Cardiac Arrhythmias

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1612 Accesses

Abstract

Ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) likely remain the most common initiating and potentially reversible mechanisms of out-of-hospital cardiac arrest and sudden cardiac death (SCD). Defibrillation is the only predictably effective therapy for reverting VF and pulseless VT to an effective rhythm for restoration of blood flow. Current indications for implantation of implantable cardioverter-defibrillators are the result of risk stratification strategies that can be divided as follows: (1) secondary prevention indications; (2) primary prevention in high-risk groups with acquired diseases; and (3) SCD prevention in selected patients with specific inherited arrhythmogenic syndromes or less common acquired diseases. Further improvement and understanding of different risk stratification strategies will eventually identify individuals at specific risk for SCD and, hence, determine the type of preventive intervention required for small, high-risk subsets of individuals, who are currently diluted within larger population groups or the general population that account for the majority of SCD victims.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Becker L, Gold LS, Eisenberg M, White L, Hearne T, Rea T (2008) Ventricular fibrillation in King County, Washington: a 30-year perspective. Resuscitation 79:22–27

    Article  PubMed  Google Scholar 

  2. Eisenberg MS, Mengert TJ (2001) Cardiac resuscitation. N Engl J Med 344:1304–1313

    Article  PubMed  CAS  Google Scholar 

  3. Atwood C, Eisenberg MS, Herlitz J, Rea TD (2005) Incidence of EMS-treated out-of-hospital cardiac arrest in Europe. Resuscitation 67:75–80

    Article  PubMed  Google Scholar 

  4. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK (2002) Changing incidence of out-of-hospital ventricular fibrillation, 1980–2000. JAMA 288:3008–3013

    Article  PubMed  Google Scholar 

  5. Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP (1997) Estimating effectiveness of cardiac arrest interventions: a logistic regression survival model. Circulation 96:3308–3313

    Article  PubMed  CAS  Google Scholar 

  6. Marenco JP, Wang PJ, Link MS, Homoud MK, Estes NA 3rd (2001) Improving survival from sudden cardiac arrest: the role of the automated external defibrillator. JAMA 285:1193–1200

    Article  PubMed  CAS  Google Scholar 

  7. Weaver WD, Peberdy MA (2002) Defibrillators in public places – one step closer to home. N Engl J Med 347:1223–1224

    Article  PubMed  Google Scholar 

  8. Passman R, Kadish A (2007) Sudden death prevention with implantable devices. Circulation 116:561–571

    Article  PubMed  Google Scholar 

  9. Beck CS, Pritchard WH, Feil HS (1947) Ventricular Fibrillation of Long Duration Abolished by Electric Shock. JAMA 135:985–986

    Article  CAS  Google Scholar 

  10. Zoll PM, Linenthal AJ, Gibson W, Paul MH, Norman LR (1956) Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med 254:727–732

    Article  PubMed  CAS  Google Scholar 

  11. Lown B, Amarasingham R, Neuman J (1962) New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA 182:548–555

    Article  PubMed  CAS  Google Scholar 

  12. ACC/AHA/HRS (2008) Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51:e1–e62

    Article  Google Scholar 

  13. Goldstein S, Landis JR, Leighton R, Ritter G, Vasu CM, Wolfe RA, Acheson A, VanderBrug Medendorp S (1985) Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease. Circulation 71:873–880

    Article  PubMed  CAS  Google Scholar 

  14. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias (1997) The antiarrhythmics versus implantable defibrillators (AVID) investigators. N Engl J Med 337:1576–1583

    Article  Google Scholar 

  15. Myerburg RJ, Reddy V, Castellanos A (2009) Indications for implantable cardioverter-defibrillators based on evidence and judgment. J Am Coll Cardiol 54:747–763

    Article  PubMed  Google Scholar 

  16. Brodsky MA, McAnulty J, Zipes DP, Baessler C, Hallstrom AP, AVID Investigators (2006) A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study. Am Heart J 152:724–730

    Article  PubMed  Google Scholar 

  17. Domanski MJ, Sakseena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E (1999) Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID investigators. Antiarrhythmics versus implantable defibrillators. J Am Coll Cardiol 34:1090–1095

    Article  PubMed  CAS  Google Scholar 

  18. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B (2000) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–302

    Google Scholar 

  19. Kuck KH, Cappato R, Siebels J, Rüppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the cardiac arrest study hamburg (CASH). Circulation 102(7):748–754

    Article  PubMed  CAS  Google Scholar 

  20. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac Arrest Study Hamburg . Canadian implantable defibrillator study. Eur Heart J 21:2071–2078

    Article  PubMed  CAS  Google Scholar 

  21. American Heart Association (2009) Heart disease and stroke statistics – 2009 update. American Heart Association, Dallas, Texas

    Google Scholar 

  22. Huikuri HV, Castellanos A, Myerburg RJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345:1473–1482

    Article  PubMed  CAS  Google Scholar 

  23. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A (1998) Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 97:1514–1s521

    Article  PubMed  CAS  Google Scholar 

  24. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med 335:1933–1940

    Article  PubMed  CAS  Google Scholar 

  25. Bigger JT Jr (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337:1569–1575

    Article  PubMed  Google Scholar 

  26. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 341:1882–1890

    Article  PubMed  CAS  Google Scholar 

  27. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML (2002) Multicenter automatic defibrillator implantation trial II investigators prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  28. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (2004) Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158

    Article  PubMed  CAS  Google Scholar 

  29. Bardy GH, Lee KL, Mark DB et al (2005) for the Sudden Cardiac Deathin Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237

    Article  PubMed  CAS  Google Scholar 

  30. Hohnloser SH, Kuck KH, Dorian P et al (2004) for the DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351:2481–2488

    Article  PubMed  CAS  Google Scholar 

  31. Moss AJ (2005) Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation 111:2537–2549

    Article  PubMed  Google Scholar 

  32. Al-Khatib SM, Sanders GD, Mark DB et al (2005) Expert panel participating in a Duke Clinical Research Institute-sponsored conference. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 149:1020–1034

    Article  PubMed  Google Scholar 

  33. Kusmirek SL, Gold MR (2007) Sudden cardiac death: the role of risk stratification. Am Heart J 153(Suppl):25–33

    Article  PubMed  Google Scholar 

  34. Gorgels AP, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJ (2003) Out-of-hospital cardiac arrest–the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 24:1204–1209

    Article  PubMed  Google Scholar 

  35. Stecker EC, Vickers C, Waltz J et al (2006) Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon sudden unexpected death study. J Am Coll Cardiol 47:1161–1166

    Article  PubMed  Google Scholar 

  36. Buxton AE, Lee KL, Hafley GE et al (2007) Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 50:1150–1157

    Article  PubMed  Google Scholar 

  37. Myerburg RJ (2008) Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 359:2245–2253

    Article  PubMed  CAS  Google Scholar 

  38. Moss AJ, Fadl Y, Zareba W, Cannom DS, Hall WJ (2001) Defibrillator Implantation Trial Research Group. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol 88:516–520

    Article  PubMed  CAS  Google Scholar 

  39. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM (2007) Statistics in medicine – reporting of subgroup analyses in clinical trials. N Engl J Med 357(21):2189–2194

    Article  PubMed  CAS  Google Scholar 

  40. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G (2000) Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter unsustained tachycardia trial investigators. N Engl J Med 342:1937–1945

    Article  PubMed  CAS  Google Scholar 

  41. Daubert JP, Zareba W, Hall WJ et al (2006) MADIT II Study Investigators. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter automatic defibrillator implantation trial (MADIT) II patients. J Am Coll Cardiol 47:98–107

    Article  PubMed  Google Scholar 

  42. Lopera G, Curtis AB (2009) Risk stratification for sudden cardiac death: current approaches and predictive value. Curr Cardiol Rev 5(1)

    Google Scholar 

  43. Hohnloser SH, Ikeda T, Bloomfield DM, Dabbous OH, Cohen RJ (2003) T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362:125–126

    Article  PubMed  CAS  Google Scholar 

  44. Lopera G, Curtis AB (2009) Role of T wave alternans testing in risk stratification for sudden cardiac death. J Med 2(1):34–40

    Google Scholar 

  45. Chow T, Kereiakes DJ, Bartone C et al (2007) Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 49:50–58

    Article  PubMed  Google Scholar 

  46. Gomes JA, Cain ME, Buxton AE, Josephson ME, Lee KL, Hafley GE (2001) Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 104:436–441

    Article  PubMed  CAS  Google Scholar 

  47. Goldenberg I, Moss AJ (2008) Long QT syndrome. J Am Coll Cardiol 51:2291–2300

    Article  PubMed  Google Scholar 

  48. Goldenberg I, Zareba W, Moss AJ (2008) Long QT syndrome. Curr Probl Cardiol 33:629–694

    Article  PubMed  Google Scholar 

  49. Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ (2007) Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J 153(4 Suppl):53–58

    Article  PubMed  Google Scholar 

  50. Zareba W, Cygankiewicz I (2008) Long QT syndrome and short QT syndrome. Prog Cardiovasc Dis 51:264–278

    Article  PubMed  Google Scholar 

  51. Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L (2008) Long-QT syndrome after age 40. Circulation 117:2192–2201

    Article  PubMed  Google Scholar 

  52. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866–1874

    Article  PubMed  Google Scholar 

  53. Maron BJ, Spirito P (2008) Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 19:1118–1126

    Article  PubMed  Google Scholar 

  54. Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L (2003) Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 26:1887–1896

    Article  PubMed  Google Scholar 

  55. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P (2000) Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342:365–373

    Article  PubMed  CAS  Google Scholar 

  56. Almquist AK, Montgomery JV, Haas TS, Maron BJ (2005) Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm 2:814–819

    Article  PubMed  Google Scholar 

  57. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED (2003) Task force on clinical expert consensus documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713

    Article  PubMed  Google Scholar 

  58. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P (2007) Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298:405–412

    Article  PubMed  CAS  Google Scholar 

  59. Cuoco FA, Spencer WH 3rd, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR (2008) Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol 52:1718–1723

    Article  PubMed  Google Scholar 

  60. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A (2005) Brugada syndrome: report of the second consensus conference: endorsed by the Heart rhythm society and the European heart rhythm association. Circulation 111:659–670

    Article  PubMed  Google Scholar 

  61. Brugada J, Brugada R, Brugada P (1998) Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 97:457–460

    Article  PubMed  CAS  Google Scholar 

  62. Muthappan P, Calkins H (2008) Arrhythmogenic right ventricular dysplasia. Prog Cardiovasc Dis 51:31–43

    Article  PubMed  Google Scholar 

  63. Wichter T, Paul M, Wollmann C, Acil T, Gerdes P, Ashraf O, Tjan TD, Soeparwata R, Block M, Borggrefe M, Scheld HH, Breithardt G, Böcker D (2004) Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109:1503–1508

    Article  PubMed  Google Scholar 

  64. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA 3rd, Buja G, Thiene G (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084–3091

    Article  PubMed  Google Scholar 

  65. Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H (2005) Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2:1188–1194

    Article  PubMed  Google Scholar 

  66. Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P, Leone G, Maury P, Anttonen O, Haissaguerre M, Gaita F (2006) Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 27:2440–2447

    Article  PubMed  Google Scholar 

  67. Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C (2004) Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43:1494–1499

    Article  PubMed  CAS  Google Scholar 

  68. Gussak I, Antzelevitch C (2000) Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms. J Electrocardiol 33:299–309

    Article  PubMed  CAS  Google Scholar 

  69. Haïssaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, Pasquié JL, Nogami A, Babuty D, Yli-Mayry S, De Chillou C, Scanu P, Mabo P, Matsuo S, Probst V, Le Scouarnec S, Defaye P, Schlaepfer J, Rostock T, Lacroix D, Lamaison D, Lavergne T, Aizawa Y, Englund A, Anselme F, O'Neill M, Hocini M, Lim KT, Knecht S, Veenhuyzen GD, Bordachar P, Chauvin M, Jais P, Coureau G, Chene G, Klein GJ, Clémenty J (2008) Sudden cardiac arrest associated with early repolarization. N Engl J Med 358:2016–2023

    Article  PubMed  Google Scholar 

  70. Haïssaguerre M, Chatel S, Sacher F, Weerasooriya R, Probst V, Loussouarn G, Horlitz M, Liersch R, Schulze-Bahr E, Wilde A, Kääb S, Koster J, Rudy Y, Le Marec H, Schott JJ (2009) Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol 20:93–98

    Article  PubMed  Google Scholar 

  71. Haïssaguerre M, Sacher F, Nogami A, Komiya N, Bernard A, Probst V, Yli-Mayry S, Defaye P, Aizawa Y, Frank R, Mantovan R, Cappato R, Wolpert C, Leenhardt A, de Roy L, Heidbuchel H, Deisenhofer I, Arentz T, Pasquié JL, Weerasooriya R, Hocini M, Jais P, Derval N, Bordachar P, Clémenty J (2009) Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol 53:612–619

    Article  PubMed  Google Scholar 

  72. Antzelevitch C (2007) Heterogeneity and cardiac arrhythmias: an overview. Heart Rhythm 4:964–972

    Article  PubMed  Google Scholar 

  73. Collura CA, Johnson JN, Moir C, Ackerman MJ (2009) Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm 6:752–759

    Article  PubMed  Google Scholar 

  74. Diaz FJ, Loewe C, Jackson A (2006) Death caused by myocarditis in WayneCounty, Michigan: a 9-year retrospective study. Am J Forensic Med Pathol 27:300–303

    Article  PubMed  Google Scholar 

  75. Soejima K, Yada H (2009) The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 20(5):578–583

    Article  PubMed  Google Scholar 

  76. Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, Prystowsky S (2009) Cardiac sarcoidosis. Am Heart J 157(1):9–21

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, University of Miami/Miller School of Medicine and the Veterans Affairs Medical Center, Miami, FL, USA

    Gustavo Lopera MD & Robert J. Myerburg MD

Authors
  1. Gustavo Lopera MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Myerburg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Main Line Health Heart Center, 100 Lancaster Ave, Wynnewood, 19096, Pennsylvania, USA

    Gan-Xin Yan

  2. Main Line Health Heart Center, 100 Lancaster Ave, Wynnewood, 19096, Pennsylvania, USA

    Peter R. Kowey

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Lopera, G., Myerburg, R.J. (2011). Indications for Implantable Cardioverter-Defibrillators. In: Yan, GX., Kowey, P. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-161-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-161-5_13

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-160-8

  • Online ISBN: 978-1-60761-161-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation